Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893478266> ?p ?o ?g. }
- W2893478266 endingPage "5488" @default.
- W2893478266 startingPage "5479" @default.
- W2893478266 abstract "Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are associated with disease-initiating stem cells that are not eliminated by conventional therapies. Transcriptomic analysis of stem and progenitor populations in MDS and AML demonstrated overexpression of STAT3 that was validated in an independent cohort. STAT3 overexpression was predictive of a shorter survival and worse clinical features in a large MDS cohort. High STAT3 expression signature in MDS CD34+ cells was similar to known preleukemic gene signatures. Functionally, STAT3 inhibition by a clinical, antisense oligonucleotide, AZD9150, led to reduced viability and increased apoptosis in leukemic cell lines. AZD9150 was rapidly incorporated by primary MDS/AML stem and progenitor cells and led to increased hematopoietic differentiation. STAT3 knockdown also impaired leukemic growth in vivo and led to decreased expression of MCL1 and other oncogenic genes in malignant cells. These studies demonstrate that STAT3 is an adverse prognostic factor in MDS/AML and provide a preclinical rationale for studies using AZD9150 in these diseases." @default.
- W2893478266 created "2018-10-05" @default.
- W2893478266 creator A5007706683 @default.
- W2893478266 creator A5007922486 @default.
- W2893478266 creator A5010123075 @default.
- W2893478266 creator A5010142096 @default.
- W2893478266 creator A5010645663 @default.
- W2893478266 creator A5011199156 @default.
- W2893478266 creator A5011273565 @default.
- W2893478266 creator A5012812748 @default.
- W2893478266 creator A5013946717 @default.
- W2893478266 creator A5017212317 @default.
- W2893478266 creator A5021065262 @default.
- W2893478266 creator A5025730778 @default.
- W2893478266 creator A5030065450 @default.
- W2893478266 creator A5030984353 @default.
- W2893478266 creator A5039886481 @default.
- W2893478266 creator A5040239548 @default.
- W2893478266 creator A5046121522 @default.
- W2893478266 creator A5047880272 @default.
- W2893478266 creator A5049032346 @default.
- W2893478266 creator A5049994646 @default.
- W2893478266 creator A5050888877 @default.
- W2893478266 creator A5053723355 @default.
- W2893478266 creator A5055805166 @default.
- W2893478266 creator A5056428008 @default.
- W2893478266 creator A5057564343 @default.
- W2893478266 creator A5059167197 @default.
- W2893478266 creator A5068962830 @default.
- W2893478266 creator A5070033578 @default.
- W2893478266 creator A5076686388 @default.
- W2893478266 creator A5077804779 @default.
- W2893478266 creator A5081180470 @default.
- W2893478266 creator A5086348646 @default.
- W2893478266 creator A5087326265 @default.
- W2893478266 date "2018-11-05" @default.
- W2893478266 modified "2023-10-16" @default.
- W2893478266 title "Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells" @default.
- W2893478266 cites W1535142282 @default.
- W2893478266 cites W1964514885 @default.
- W2893478266 cites W1974376373 @default.
- W2893478266 cites W1979882109 @default.
- W2893478266 cites W1980521997 @default.
- W2893478266 cites W2007172221 @default.
- W2893478266 cites W2009886857 @default.
- W2893478266 cites W2027950772 @default.
- W2893478266 cites W2041204531 @default.
- W2893478266 cites W2047270485 @default.
- W2893478266 cites W2055521874 @default.
- W2893478266 cites W2075542228 @default.
- W2893478266 cites W2076031927 @default.
- W2893478266 cites W2088802752 @default.
- W2893478266 cites W2095286549 @default.
- W2893478266 cites W2101454196 @default.
- W2893478266 cites W2108244474 @default.
- W2893478266 cites W2121401558 @default.
- W2893478266 cites W2122742344 @default.
- W2893478266 cites W2126448969 @default.
- W2893478266 cites W2141048422 @default.
- W2893478266 cites W2151199601 @default.
- W2893478266 cites W2152526557 @default.
- W2893478266 cites W2162825929 @default.
- W2893478266 cites W2171224722 @default.
- W2893478266 cites W2174791834 @default.
- W2893478266 cites W2464492076 @default.
- W2893478266 cites W2533952864 @default.
- W2893478266 cites W2551607099 @default.
- W2893478266 cites W2559601897 @default.
- W2893478266 cites W2560012305 @default.
- W2893478266 cites W2585106732 @default.
- W2893478266 cites W2589060305 @default.
- W2893478266 cites W2600519390 @default.
- W2893478266 cites W2624920353 @default.
- W2893478266 cites W2765483614 @default.
- W2893478266 cites W2770748248 @default.
- W2893478266 cites W2771247031 @default.
- W2893478266 cites W2781668746 @default.
- W2893478266 doi "https://doi.org/10.1172/jci120156" @default.
- W2893478266 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6264739" @default.
- W2893478266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30252677" @default.
- W2893478266 hasPublicationYear "2018" @default.
- W2893478266 type Work @default.
- W2893478266 sameAs 2893478266 @default.
- W2893478266 citedByCount "59" @default.
- W2893478266 countsByYear W28934782662019 @default.
- W2893478266 countsByYear W28934782662020 @default.
- W2893478266 countsByYear W28934782662021 @default.
- W2893478266 countsByYear W28934782662022 @default.
- W2893478266 countsByYear W28934782662023 @default.
- W2893478266 crossrefType "journal-article" @default.
- W2893478266 hasAuthorship W2893478266A5007706683 @default.
- W2893478266 hasAuthorship W2893478266A5007922486 @default.
- W2893478266 hasAuthorship W2893478266A5010123075 @default.
- W2893478266 hasAuthorship W2893478266A5010142096 @default.
- W2893478266 hasAuthorship W2893478266A5010645663 @default.
- W2893478266 hasAuthorship W2893478266A5011199156 @default.
- W2893478266 hasAuthorship W2893478266A5011273565 @default.
- W2893478266 hasAuthorship W2893478266A5012812748 @default.